Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis
暂无分享,去创建一个
G. Barker | A. Thompson | A. Hadjiprocopis | D. Chard | W. Rashid | G. Davies | R. Kapoor | C. Griffin | D. Miller | L. Ramió-Torrentà | L. Ramió-Torrentà | D. Miller
[1] P. M. Matthews,et al. Evidence of early cortical atrophy in MS , 2003, Neurology.
[2] M. Horsfield,et al. A 6‐year clinical and MRI follow‐up study of patients with relapsing–remitting multiple sclerosis treated with Interferon‐beta , 2002, European journal of neurology.
[3] Wolfgang Brück,et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.
[4] P Kapeller,et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[5] G. Barker,et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS , 2002, Neurology.
[6] F Barkhof,et al. The role of MRI as a surrogate outcome measure in multiple sclerosis , 2002, Multiple sclerosis.
[7] A J Thompson,et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[8] David H. Miller,et al. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis , 2002, Journal of Neurology.
[9] Jayaram K. Udupa,et al. Magnetization Transfer Ratio Histogram Analysis of Normal-Appearing Gray Matter and Normal-Appearing White Matter in Multiple Sclerosis , 2002, Journal of computer assisted tomography.
[10] L. Kappos,et al. Clinical–MRI correlations in a European trial of interferon beta-1b in secondary progressive MS , 2001, Neurology.
[11] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[12] B K Rutt,et al. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS , 2000, Journal of magnetic resonance imaging : JMRI.
[13] Nikos Evangelou,et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.
[14] F. Barkhof,et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.
[15] S. Reingold,et al. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.
[16] A J Thompson,et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. , 1999, Neurology.
[17] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.
[18] ichard,et al. AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS , 1998 .
[19] F. Lublin,et al. Management of patients receiving interferon beta-1b for multiple sclerosis , 1996, Neurology.
[20] G. Barker,et al. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. , 1996, Magnetic resonance imaging.
[21] M Filippi,et al. A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.
[22] R I Grossman,et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.
[23] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[24] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[25] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.